The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 15, 2023

Filed:

Jan. 14, 2021
Applicant:

Tata Consultancy Services Limited, Mumbai, IN;

Inventors:

Dibyendu Roy, Kolkata, IN;

Oishee Mazumder, Kolkata, IN;

Aniruddha Sinha, Kolkata, IN;

Sundeep Khandelwal, Noida, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/50 (2018.01); G16H 20/30 (2018.01); G16H 40/67 (2018.01); G16H 70/60 (2018.01); G16H 50/70 (2018.01); A61N 1/36 (2006.01);
U.S. Cl.
CPC ...
G16H 50/50 (2018.01); G16H 20/30 (2018.01); G16H 40/67 (2018.01); G16H 50/70 (2018.01); G16H 70/60 (2018.01); A61N 1/36114 (2013.01);
Abstract

This disclosure provides a simulation platform to study and perform predictive analysis on valvular heart disease, Mitral stenosis (MS) and provides a control approach to correct hemodynamic imbalances during MS conditions. Conventional approaches of valve repair or replacement are often associated with risk of thromboembolism, need for anticoagulation, prosthetic endocarditis, and impaired left ventricle function. The cardiovascular hemodynamics model of the present disclosure helps to create 'what if' conditions to study variations in different hemodynamic parameters like blood flow, aortic and ventricular pressure, etc. during normal and pathological conditions. An adaptive control system in conjunction with the hemodynamic cardiovascular system (CVS) is provided to handle hemodynamic disbalance during moderate to severe MS conditions. The adaptive controller is hypothesized in line with the neuromodulation approach and modulates left ventricular contractility and vagal tone to counter the symptoms associated with MS.


Find Patent Forward Citations

Loading…